← Back to Clinical Trials
Recruiting NCT06558630

NCT06558630 ED Airway Management in the Netherlands.

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT06558630
Status Recruiting
Phase
Sponsor Frisius Medisch Centrum
Condition Endotracheal Intubation
Study Type OBSERVATIONAL
Enrollment 1,000 participants
Start Date 2024-01-01
Primary Completion 2027-01-01

Eligibility & Interventions

Sex All sexes
Min Age N/A
Max Age N/A
Study Type OBSERVATIONAL
Interventions
Endotracheal intubation

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.

This trial targets 1,000 participants in total. It began in 2024-01-01 with a primary completion date of 2027-01-01.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

Airway management is one of the resuscitative procedures patients may undergo in the Emergency Department (ED). While this is a high risk procedure, to date there is no data available on airway management practices, success or safety in EDs in the Netherlands. The objective of this study is to describe airway management in the Netherlands.

Eligibility Criteria

Inclusion Criteria: * All patients who undergo airway management in the ED. Exclusion Criteria: * ED patients that undergo airway management outside of the ED (e.g. operation room), will be excluded

Contact & Investigator

Central Contact

P Veldhuis, MD

✉ peter.veldhuis@mcl.nl

📞 +3158 286 6666

Frequently Asked Questions

Who can join the NCT06558630 clinical trial?

This trial is open to participants of all sexes, studying Endotracheal Intubation. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT06558630 currently recruiting?

Yes, NCT06558630 is actively recruiting participants. Contact the research team at peter.veldhuis@mcl.nl for enrollment information.

Where is the NCT06558630 trial being conducted?

This trial is being conducted at Leeuwarden, Netherlands.

Who is sponsoring the NCT06558630 clinical trial?

NCT06558630 is sponsored by Frisius Medisch Centrum. The trial plans to enroll 1,000 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: July 2026  ·  Data Methodology